Asia Pacific Home Infusion Therapy Market Size & Outlook
Asia Pacific home infusion therapy market, 2018-2030 (US$M)
Related Markets
Asia Pacific home infusion therapy market highlights
- The Asia Pacific home infusion therapy market generated a revenue of USD 5,339.0 million in 2023.
- The market is expected to grow at a CAGR of 9.9% from 2024 to 2030.
- In terms of segment, anti-infective was the largest revenue generating application in 2023.
- Endocrinology is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 5,339.0 million |
| Market revenue in 2030 | USD 10,305.9 million |
| Growth rate | 9.9% (CAGR from 2023 to 2030) |
| Largest segment | Anti-infective |
| Fastest growing segment | Endocrinology |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
| Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 14.8% of the global home infusion therapy market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 10,305.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Home Infusion Therapy Market Scope
Home Infusion Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific home infusion therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.68% in 2023. Horizon Databook has segmented the Asia Pacific home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
The home infusion therapy market in Asia Pacific is expected to witness a high growth during the forecast period. This can be attributed to high unmet needs in emerging market such as China, and Japan. Moreover, rising awareness about the benefits of home infusion therapies over in-hospital infusion therapy procedures among patients is expected to fuel market growth in this region.
Reasons to subscribe to Asia Pacific home infusion therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific home infusion therapy market databook
-
Our clientele includes a mix of home infusion therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific home infusion therapy market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific home infusion therapy market size, by country, 2018-2030 (US$M)
Asia Pacific Home Infusion Therapy Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
